Clinical Trial Update: A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Lorundrostat for obstructive sleep apnea and hypertension has completed. The study was sponsored by Mineralys Therapeutics I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obstructive Sleep Apnea

Drugs mentioned

• Lorundrostat (lorundrostat)

Snippet

Sponsor: Mineralys Therapeutics Inc. | Conditions: Obstructive Sleep Apnea, Hypertension | Phase 2 | Status: COMPLETED